State CT
Clinical Trials in Connecticut
Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.
Top Conditions in Connecticut
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
NCT06632457 Phase 3
Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a L...
Condition
Metabolic Dysfunction Associated Steatohepatitis
Enrollment
1,590 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07457736 EARLY_Phase 1
Recruiting
Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA ...
Condition
Healthy Adult Participants
Enrollment
32 pts
Location
United States
Sponsor
Yale University
NCT05155163 N/A
Recruiting
Stepped Care for Patients to Optimize Whole Recovery
Condition
Opioid Use Disorder
Enrollment
204 pts
Location
United States
Sponsor
Yale University
NCT05981833 N/A
Recruiting
Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears
Condition
Full-thickness Rotator Cuff Tear
Enrollment
120 pts
Location
United States
Sponsor
Arthrex, Inc.
NCT03394365 Phase 3
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associ...
Condition
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
Enrollment
115 pts
Location
United States, Australia, Austria
Sponsor
Pierre Fabre Medicament
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
210 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT07378592 N/A
Recruiting
Driving Simulator Training For Adults With Acquired Brain Injuries
Condition
Acquired Brain Injury
Enrollment
50 pts
Location
United States
Sponsor
Sacred Heart University
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05784805 N/A
Recruiting
Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilept...
Condition
Seizures
Enrollment
10 pts
Location
United States
Sponsor
Yale University
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT06824467 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870)...
Condition
Ovarian Cancer
Enrollment
770 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06541704 Phase 3
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With ...
Condition
Age-related Macular Degeneration (AMD)
Enrollment
975 pts
Location
United States, Austria, Canada
Sponsor
Regeneron Pharmaceuticals
NCT05106387 N/A
Recruiting
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-19...
Condition
Chronic Kidney Disease (CKD)
Enrollment
20 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT03334292 N/A
Recruiting
Natural History of Wilson Disease
Condition
Wilson Disease
Enrollment
300 pts
Location
United States, Germany, United Kingdom
Sponsor
Yale University
NCT03860883 N/A
Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Sta...
Condition
Cutaneous Melanoma, Stage II
Enrollment
2,998 pts
Location
United States, Australia, Canada
Sponsor
Melanoma and Skin Cancer Trial
NCT06609369 Phase 2
Recruiting
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
Condition
Tobacco Use
Enrollment
114 pts
Location
United States
Sponsor
Yale University
NCT06368817 Phase 2
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Condition
Basal Ganglia Germinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07285018 Phase 2
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
150 pts
Location
United States, Puerto Rico
Sponsor
Eli Lilly and Company
NCT06672510 N/A
Recruiting
Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal...
Condition
Pulmonary Embolism Acute
Enrollment
118 pts
Location
United States
Sponsor
Akura Medical
NCT04804644 Phase 3
Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Who...
Condition
Metastatic Lung Small Cell Carcinoma
Enrollment
200 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT06999434 Phase 1
Recruiting
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Condition
Demyelinating Disorders
Enrollment
105 pts
Location
United States
Sponsor
Yale University
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT04704271 Phase 1
Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol ...
Condition
Cannabis
Enrollment
100 pts
Location
United States
Sponsor
Yale University
NCT01915511 N/A
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes...
Condition
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Enrollment
3,000 pts
Location
United States
Sponsor
Duke University